Keyphrases
Positron Emission Tomography
89%
Human Brain
68%
Cocaine
66%
Dopamine
64%
Methylphenidate
49%
Dopamine Transporter
41%
Baboon
41%
Metabolism
30%
Monoamine Oxidase A (MAO-A)
28%
Radiotracer
27%
Abusers
26%
Dopamine D2 Receptor (DRD2)
25%
Striatum
25%
Carbon-11
25%
Raclopride
24%
Positron Emission Tomography Study
23%
Imaging Studies
21%
Addiction
20%
Cerebellum
20%
D2 Receptor
19%
Brain Glucose Metabolism
19%
PET Study
18%
Striatal
18%
Monoamine Oxidase B (MAO-B)
18%
Orbitofrontal Cortex
16%
Radioactivity
16%
Radiochemical Yield
15%
Radioligand
14%
Volume of Distribution
14%
Pharmacokinetics
14%
18F-fluorodeoxyglucose (18F-FDG)
14%
Specific Activity
13%
Fluorodeoxyglucose
13%
Deprenyl
13%
Brain Monoamines
12%
Drug Addiction
12%
Brain Metabolism
11%
Basal Ganglia
11%
Brain Regions
11%
Fluorine-18
11%
Glucose Metabolism
10%
Cocaine Dependence
10%
Alcoholic
10%
Methamphetamine
10%
Obesity
10%
Fluoro
10%
Drug Abuse
10%
Radiosynthesis
9%
Nucleus Accumbens
9%
Occupancy
9%
Neuroscience
Positron Emission Tomography
100%
Metabolic Pathway
68%
Methylphenidate
49%
Positron Emission Tomography
47%
Fluorine-18
46%
Dopamine Transporter
42%
Receptor
40%
Striatum
36%
In Vivo
34%
Dopamine Receptor D2
28%
Raclopride
27%
Blood Plasma
25%
Cerebellum
24%
Orbitofrontal Cortex
22%
Monoamine Oxidase A
20%
Brain Metabolism
17%
Behavior (Neuroscience)
15%
Thalamus
15%
Radioligand
14%
Pharmacokinetics
14%
Dopamine Release
13%
Gyri
13%
Basal Ganglia
12%
Monoamine Oxidase B
11%
Drug Abuse
11%
Dopaminergic
10%
Lorazepam
10%
Cocaine Dependence
10%
Nucleus Accumbens
10%
Neurotransmitter
9%
Monoamine Oxidase
9%
Aromatase
8%
Putamen
8%
Attention Deficit Hyperactivity Disorder
8%
Analeptic
8%
Typical Antipsychotic
8%
Dopamine Receptor
8%
Executive Function
7%
2-Deoxy-D-Glucose
7%
Brain Imaging
7%
Amygdala
7%
Placebo
7%
Brain Function
7%
Synaptic Transmission
6%
Gamma-Aminobutyric Acid
6%
Glucose
6%
Alzheimer's Disease
6%
Hippocampus
6%
Clorgiline
6%
Binding Site
6%